BE628212A - - Google Patents
Info
- Publication number
- BE628212A BE628212A BE628212DA BE628212A BE 628212 A BE628212 A BE 628212A BE 628212D A BE628212D A BE 628212DA BE 628212 A BE628212 A BE 628212A
- Authority
- BE
- Belgium
- Prior art keywords
- cells
- virus
- bhk
- culture
- foot
- Prior art date
Links
- 210000004027 cell Anatomy 0.000 claims description 91
- 241000700605 Viruses Species 0.000 claims description 49
- 239000002609 medium Substances 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 12
- 241000710198 Foot-and-mouth disease virus Species 0.000 claims description 10
- 229960005486 vaccine Drugs 0.000 claims description 9
- 241001505332 Polyomavirus sp. Species 0.000 claims description 8
- 210000003734 kidney Anatomy 0.000 claims description 8
- 235000015097 nutrients Nutrition 0.000 claims description 8
- 239000000725 suspension Substances 0.000 claims description 8
- 229910019142 PO4 Inorganic materials 0.000 claims description 7
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 7
- 239000010452 phosphate Substances 0.000 claims description 7
- 210000000630 fibrocyte Anatomy 0.000 claims description 6
- 239000001963 growth medium Substances 0.000 claims description 6
- 241000699673 Mesocricetus auratus Species 0.000 claims description 5
- 150000001413 amino acids Chemical class 0.000 claims description 5
- 238000004113 cell culture Methods 0.000 claims description 5
- 235000013343 vitamin Nutrition 0.000 claims description 5
- 229940088594 vitamin Drugs 0.000 claims description 5
- 229930003231 vitamin Natural products 0.000 claims description 5
- 239000011782 vitamin Substances 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 4
- 241000699800 Cricetinae Species 0.000 claims description 3
- 208000007212 Foot-and-Mouth Disease Diseases 0.000 claims description 2
- 239000012888 bovine serum Substances 0.000 claims description 2
- 239000012531 culture fluid Substances 0.000 claims 1
- 210000002966 serum Anatomy 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 244000309466 calf Species 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 241000711404 Avian avulavirus 1 Species 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 3
- 241000712469 Fowl plague virus Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 201000001371 inclusion conjunctivitis Diseases 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 210000003292 kidney cell Anatomy 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000002356 single layer Substances 0.000 description 3
- 206010044325 trachoma Diseases 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000700584 Simplexvirus Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000005273 aeration Methods 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 241000725619 Dengue virus Species 0.000 description 1
- 241001492218 Foot-and-mouth disease virus - type SAT 2 Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 101710154606 Hemagglutinin Proteins 0.000 description 1
- 241000712431 Influenza A virus Species 0.000 description 1
- 108090000942 Lactalbumin Proteins 0.000 description 1
- 102000004407 Lactalbumin Human genes 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 101710093908 Outer capsid protein VP4 Proteins 0.000 description 1
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 101710176177 Protein A56 Proteins 0.000 description 1
- 101710140501 Sulfate adenylyltransferase subunit 2 1 Proteins 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 239000013553 cell monolayer Substances 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 210000003837 chick embryo Anatomy 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000000120 cytopathologic effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229910001651 emery Inorganic materials 0.000 description 1
- 230000003328 fibroblastic effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000000185 hemagglutinin Substances 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 208000037797 influenza A Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940049018 mycostatin Drugs 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- VQOXZBDYSJBXMA-NQTDYLQESA-N nystatin A1 Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 VQOXZBDYSJBXMA-NQTDYLQESA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000005297 pyrex Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000004114 suspension culture Methods 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32161—Methods of inactivation or attenuation
- C12N2770/32164—Methods of inactivation or attenuation by serial passage
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Virology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE628212A true BE628212A (https=) |
Family
ID=198197
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE628212D BE628212A (https=) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE628212A (https=) |
-
0
- BE BE628212D patent/BE628212A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Paterna et al. | Isolation of extracellular vesicles from microalgae: a renewable and scalable bioprocess | |
| Van Hemert et al. | Homogeneous cultivation of animal cells for the production of virus and virus products | |
| CN1147833A (zh) | 甲型肝炎病毒培养工艺 | |
| EP0549774A1 (fr) | Utilisation de carbonate de calcium poreux comme materiau support de culture de cellules in vitro | |
| EP2516623A1 (fr) | Procede de culture de cellules adherentes | |
| JP2633392B2 (ja) | ウイルス／ウイルス抗原を生産するためのバイオマス | |
| CN108220227A (zh) | 一种通过全悬浮传代细胞系悬浮培养新城疫病毒的方法 | |
| US3935066A (en) | Cell lines | |
| RU2082757C1 (ru) | Субстрат для культивирования флавивирусов или ареновирусов на основе культуры клеток и способ получения антигена флавивируса или ареновируса | |
| LU79891A1 (fr) | Procede de culture de virus | |
| BE628212A (https=) | ||
| US5719051A (en) | Perfusion system and a method for the large scale production of virus or virus antigen | |
| WO2004110484A1 (en) | Method for producing a live tissue-cultural vaccine against influenza virus | |
| JPH0998778A (ja) | マレク病ワクチン | |
| CN105779373A (zh) | 一种适宜稻曲病菌产孢的核糖培养基及其应用方法 | |
| CN105950559B (zh) | 一种神经母细胞瘤在手性金纳米粒子薄膜上分化的方法 | |
| Fong et al. | Use of electron microscopy for detection of viral and other microbial contaminants in bovine sera | |
| Aunins et al. | Vaccine production | |
| RU2723580C1 (ru) | Способ получения адсорбированной вакцины против вибриоза лососевых рыб | |
| US3228840A (en) | Virus culture | |
| RU2014084C1 (ru) | Способ получения вирионной герпетической вакцины | |
| Bana et al. | Biomedical Application of Industrial Microbiology | |
| JPS63501474A (ja) | 細胞を培養するための微小担体を製造するための方法及び該方法によって製造された微小担体 | |
| CN104312981A (zh) | 脊髓灰质炎灭活疫苗及其生产方法 | |
| JP7759932B2 (ja) | カルミン酸を得るための方法 |